C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 7/06 (2006.01) A61K 51/08 (2006.01) C07B 59/00 (2006.01) C07D 207/34 (2006.01) C07D 213/77 (2006.01) C07D 213/80 (2006.01) C07D 231/38 (2006.01) C07D 233/88 (2006.01) C07D 237/20 (2006.01) C07D 239/42 (2006.01) C07D 241/20 (2006.01) C07D 401/12 (2006.01) C07D 405/12 (2006.01) C07F 13/00 (2006.01)
Patent
CA 2167167
Radionuclide chelating compounds are provided for conjugation to targeting molecules such as proteins, peptides or antibodies. The resulting labelled targeting molecules may be used in diagnosis and therapy.
L'invention concerne des composés de chélation des radionucléides utilisés pour la conjugaison avec des molécules de ciblage telles que des protéines, des peptides ou des anticorps. Les molécules de ciblage marquées résultantes peuvent être utilisées à des fins diagnostiques et thérapeutiques.
Dufault Robert
Kirby Robert A.
Pollak Alfred
Bracco International B.v.
Dimock Stratton Llp
Resolution Pharmaceuticals Inc.
LandOfFree
Hydrazino-type radionuclide chelators having an n3s... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrazino-type radionuclide chelators having an n3s..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrazino-type radionuclide chelators having an n3s... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1707429